» Articles » PMID: 15146036

The Present and Future Management of Malignant Brain Tumours: Surgery, Radiotherapy, Chemotherapy

Overview
Date 2004 May 18
PMID 15146036
Citations 22
Authors
Affiliations
Soon will be listed here.
Citing Articles

Advancing CNS Therapeutics: Enhancing Neurological Disorders with Nanoparticle-Based Gene and Enzyme Replacement Therapies.

Liu S, Li H, Xi S, Zhang Y, Sun T Int J Nanomedicine. 2025; 20:1443-1490.

PMID: 39925682 PMC: 11806685. DOI: 10.2147/IJN.S457393.


Dosimetric evaluation and treatment planning considerations for GammaTile permanent brain implants - a pilot, institutional experience.

Zhang S, Patel K, Dusenbery K, Alshreef A, Sterling D, Sloan L J Neurooncol. 2024; 169(1):11-23.

PMID: 38902561 DOI: 10.1007/s11060-024-04631-4.


Dosimetric Impact of Source Displacement in GammaTile Surgically Targeted Radiation Therapy for Gliomas.

Ng S, Yue Y, Shiue K, Shah M, Le Y Cureus. 2023; 15(5):e38463.

PMID: 37273347 PMC: 10234842. DOI: 10.7759/cureus.38463.


Lipid nanostructures for targeting brain cancer.

Nsairat H, Khater D, Odeh F, Al-Adaileh F, Al-Taher S, Jaber A Heliyon. 2021; 7(9):e07994.

PMID: 34632135 PMC: 8488847. DOI: 10.1016/j.heliyon.2021.e07994.


Non-coplanar VMAT plans for postoperative primary brain tumour to reduce dose to hippocampus, temporal lobe and cochlea: a planning study.

Cheung E, Lee K, Lau W, Lau A, Wat P BJR Open. 2021; 3(1):20210009.

PMID: 34381950 PMC: 8320115. DOI: 10.1259/bjro.20210009.


References
1.
Westphal M, Giese A . Local control of gliomas: the next best step--a good step?. Front Radiat Ther Oncol. 1999; 33:214-26. DOI: 10.1159/000061237. View

2.
Stewart L . Chemotherapy in adult high-grade glioma: a systematic review and meta-analysis of individual patient data from 12 randomised trials. Lancet. 2002; 359(9311):1011-8. DOI: 10.1016/s0140-6736(02)08091-1. View

3.
Basso U, Ermani M, Vastola F, Brandes A . Non-cytotoxic therapies for malignant gliomas. J Neurooncol. 2002; 58(1):57-69. DOI: 10.1023/a:1015839111005. View

4.
Cairncross J, Ueki K, Zlatescu M, Lisle D, Finkelstein D, Hammond R . Specific genetic predictors of chemotherapeutic response and survival in patients with anaplastic oligodendrogliomas. J Natl Cancer Inst. 1998; 90(19):1473-9. DOI: 10.1093/jnci/90.19.1473. View

5.
Laws E, Parney I, Huang W, Anderson F, Morris A, Asher A . Survival following surgery and prognostic factors for recently diagnosed malignant glioma: data from the Glioma Outcomes Project. J Neurosurg. 2003; 99(3):467-73. DOI: 10.3171/jns.2003.99.3.0467. View